Metraipolis › archive › dc_0bf47c460bbb

Comparative efficacy of naltrexone-accelerated versus sublingual buprenorphine in opioid withdrawal management and initiating injectable naltrexone treatment:… — Europe PMC PMID:42909039

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42909039
DOI
10.3389/fpsyt.2026.1933443
License (as archived)
solo-consultazione
Archived
2026-11-01T02:09:31.908Z
SHA-256 of the archived text
d75e286517cc2d1c7be31a140a2d1d87d48b7bbe87cdc1bb55c9cb36d65b5508
Stable URL of this page
https://metraipolis.com/documento/dc_0bf47c460bbb

How to cite

Comparative efficacy of naltrexone-accelerated versus sublingual buprenorphine in opioid withdrawal management and initiating injectable naltrexone treatment:… — Europe PMC PMID:42909039 — Europe PMC (en), https://europepmc.org/article/MED/42909039 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0bf47c460bbb (Metraipolis archive dc_0bf47c460bbb, sha256 d75e286517cc2d1c7be31a140a2d1d87d48b7bbe87cdc1bb55c9cb36d65b5508)
BibTeX
@misc{dc0bf47c460bbb,
  title = {Comparative efficacy of naltrexone-accelerated versus sublingual buprenorphine in opioid withdrawal management and initiating injectable naltrexone treatment:… — Europe PMC PMID:42909039},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42909039},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0bf47c460bbb; sha256 d75e286517cc2d1c7be31a140a2d1d87d48b7bbe87cdc1bb55c9cb36d65b5508},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42909039. Agents can read the archived copy with the MCP tool read_document.